Evidence map›Paper›PMID 31903811›Full record

ReviewExpert review of vaccines2020

Progress in the development of virus-like particle vaccines against respiratory viruses.

Fu-Shi Quan, Swarnendu Basak, Ki-Back Chu, Sung Soo Kim, Sang-Moo Kang

Open access · bronzeAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Expert review of vaccines, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Use of Protamine in Nanopharmaceuticals-A Review.Nanomaterials (Basel, Switzerland) · 2021
    Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Fu-Shi QuanDepartment of Medical Zoology, Kyung Hee University School of Medicine, Seoul, Republic of Korea.
Swarnendu BasakDepartment of Biomedical Science, Graduate School, Kyung Hee University, Seoul, Republic of Korea.
Ki-Back ChuDepartment of Biomedical Science, Graduate School, Kyung Hee University, Seoul, Republic of Korea.
Sung Soo KimMedical Research Center for Bioreaction to Reactive Oxygen Species and Biomedical Science Institute, School of Medicine, Graduate school, Kyung Hee University, Seoul, Republic of Korea.ORCID 0000-0002-4195-0980
Sang-Moo KangInstitute for Biomedical Sciences, Georgia State University, Atlanta, GA, USA.
Kyung Hee University · KRGeorgia State University · US

Funding

Influenza vaccines inducing broadly cross protective immunityR01AI093772 · NIAID · GEORGIA STATE UNIVERSITY · PI KANG, SANG-MOO · 2011 to 2020
$4.2M
VLP Vaccine TechnologyR01AI105170 · NIAID · GEORGIA STATE UNIVERSITY · PI KANG, SANG-MOO · 2013 to 2017
$3.7M
New RSV Vaccines with Improved Safety and EfficacyR41AI134132 · NIAID · ADVAC, LLC · PI KANG, SANG-MOO · 2018 to 2018
$225k
NIAID NIH HHS R01 AI093772NIAID NIH HHS R01 AI105170NIAID NIH HHS R41 AI134132
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsHumansInfluenza, HumanInfluenza VaccinesNanoparticlesParamyxoviridae InfectionsRespiratory Syncytial Virus InfectionsRespiratory Syncytial Virus VaccinesVaccines, Virus-Like ParticleViral VaccinesInfluenza VaccinesRespiratory Syncytial Virus VaccinesVaccines, Virus-Like ParticleViral VaccinesHuman metapneumovirus virusInfluenza virusProtectionRespiratory syncytial virusVaccinesVirus-like particles

Identifiers

PMID31903811
PMCPMC7103727
OpenAlexW2997955057

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.